Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Mutual Pharmaceutical Company, Inc.

Mutual Pharmaceutical Company, Inc. Recalls

All product recalls associated with Mutual Pharmaceutical Company, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

303

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 3041–3060 of 4747 recalls

Imipramine HCl 10 mg (Mutual) – Chemical Contamination (2015)

Chemical Contamination; benzophenone leached from the product label varnish

Class IIILow

FDAJul 16, 2015Nationwide• Mutual Pharmaceutical Company, Inc.

Felodipine 5 mg (Mutual) – Chemical Contamination (2015)

Chemical Contamination; benzophenone leached from the product label varnish

Class IIILow

FDAJul 16, 2015Nationwide• Mutual Pharmaceutical Company, Inc.

Felodipine 2.5 mg (Mutual) – Chemical Contamination (2015)

Chemical Contamination; benzophenone leached from the product label varnish

Class III

1...151 152153154 155...238

Page 153 of 238Next

Low

FDAJul 16, 2015Nationwide• Mutual Pharmaceutical Company, Inc.

Felodipine 10 mg (Mutual) – Chemical Contamination (2015)

Chemical Contamination; benzophenone leached from the product label varnish

Class IIILow

FDAJul 16, 2015Nationwide• Mutual Pharmaceutical Company, Inc.

Imipramine HCl 25 mg (Mutual) – Chemical Contamination (2015)

Chemical Contamination; benzophenone leached from the product label varnish

Class IIILow

FDAJul 16, 2015Nationwide• Mutual Pharmaceutical Company, Inc.

Mometasone Furoate Ointment (Perrigo) – subpotent drug (2015)

Subpotent drug

Class IIILow

FDAJul 13, 2015Nationwide• Perrigo Israel Pharmaceuticals

Clonidine Tablets 0.1mg (PD-Rx) – manufacturing deviation (2015)

cGMP Deviations

Class IIModerate

FDAJul 10, 2015AL• PD-Rx Pharmaceuticals, Inc.

Clonidine Tablets 0.2mg (Mutual) – manufacturing deviation (2015)

cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer

Class IIModerate

FDAJul 9, 2015Nationwide• Mutual Pharmaceutical Company, Inc.

Clonidine Tablets 0.3mg (Mutual) – manufacturing deviation (2015)

cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer

Class IIModerate

FDAJul 9, 2015Nationwide• Mutual Pharmaceutical Company, Inc.

Clonidine Tablets 0.1mg (Mutual) – manufacturing deviation (2015)

cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer

Class IIModerate

FDAJul 9, 2015Nationwide• Mutual Pharmaceutical Company, Inc.

Nitroglycerin Patch 0.2mg (Kremers Urban) – impurity issue (2015)

Failed Impurities/Degradation Specifications: failed specification for unknown impurity at the 24 month stability testing.

Class IIModerate

FDAJul 7, 2015Nationwide• Kremers Urban Pharmaceuticals, Inc.

Nitroglycerin Patch 0.4mg (Kremers Urban) – impurity issue (2015)

Failed Impurities/Degradation Specifications: Two lots failed specification for unknown impurity at the 24 month stability testing.

Class IIModerate

FDAJul 7, 2015Nationwide• Kremers Urban Pharmaceuticals, Inc.

Capecitabine Tablets (Mylan) – dissolution failure (2015)

Failed Dissolution Specifications: low out-of-specification (OOS) results for dissolution were obtained at the nine-month stability point.

Class IIModerate

FDAJun 30, 2015Nationwide• Mylan Pharmaceuticals Inc

HydrOXYzine Tablets (Qualitest) – unreadable tablet codes (2015)

Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable

Class IIILow

FDAJun 29, 2015Nationwide• Qualitest Pharmaceuticals

Dextroamphetamine Combination (Teva) – impurity specification (2015)

Failed Impurities/Degradation Specifications: out of specification for unknown impurity

Class IIModerate

FDAJun 24, 2015Nationwide• Teva Pharmaceuticals USA

Disulfiram Tablets (Qualitest) – Failed Dissolution Test (2015)

Failed Dissolution Specifications: During routine stability testing at the 12 month time point, one product lot was found to be out of specification for dissolution.

Class IIILow

FDAJun 18, 2015Nationwide• Qualitest Pharmaceuticals

NEXIUM Capsules (AstraZeneca) – foreign tablets (2015)

Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.

Class IIModerate

FDAJun 10, 2015Nationwide• AstraZeneca Pharmaceuticals LP